Group name
ePLND without ICG
Groups remarks
control group
Age
63 (52–78)
PSA
8.0 (1.7-28.9)
Prostate volume
39 (21-81)
Prostate volume remark
Volume prostate ml
Tumor volume
3.0 (0.2-37)
Tumor volume remark
Volume carcinoma ml